论文部分内容阅读
一、序言近年来,医学界各个领域都关注着无创伤经皮血气测量技术的发展。由于这种技术具有无创伤性和连续性并及时反映治疗效果,因此它不仅已长规地应用于危重病新生儿的血气测量监护,而且已显示出在麻醉和危重成年病人应用的可能性和优越性。 1973年Huch和Lubbert首先试制了经皮二氧化碳(PtcCO_2)传感器,而后虽然不断发展和完善,但它在商业和临床上的应用却落后于经皮氧(PtcO_2)检测技术。这是由于加热后传感器的补偿加热和热传输效应使新生儿的PtcO_2值近似于动脉氧PaO_2值。而PtcCO_2传感器的加热,虽然加快了
First, the preface In recent years, all areas of the medical field are concerned about the development of noninvasive percutaneous blood gas measurement technology. Because of its non-invasiveness and continuity and timely response to treatment, it has not only been routinely used for the monitoring of blood gases in critically ill newborns, but has also demonstrated the potential for use in anesthetized and critically ill adult patients and Superiority. In 1973, Huch and Lubbert first tried on the PtcCO_2 sensor, and after that, Huntsman and Lubbert lagged behind the detection of percutaneous oxygen (PtcO_2) for its commercial and clinical applications. This is due to the compensated heating and heat transfer effect of the sensor after heating, which makes the newborn’s PtcO_2 value approximate to the PaO_2 value of arterial oxygen. The PtcCO_2 sensor heats up, though